Spred-1 negatively regulates interleukin-3-mediated ERK/mitogen-activated protein (MAP) kinase activation in hematopoietic cells.
about
Spred2 interaction with the late endosomal protein NBR1 down-regulates fibroblast growth factor receptor signalingmiR-126 regulates angiogenic signaling and vascular integritySpred1 and TESK1--two new interaction partners of the kinase MARKK/TAO1 that link the microtubule and actin cytoskeletonNovel candidate genes and regions for childhood apraxia of speech identified by array comparative genomic hybridizationComputational approaches for discovery of common immunomodulators in fungal infections: towards broad-spectrum immunotherapeutic interventions.The VASP-Spred-Sprouty domain puzzle.Spred1, a negative regulator of Ras-MAPK-ERK, is enriched in CNS germinal zones, dampens NSC proliferation, and maintains ventricular zone structure.FoxO3a regulates hematopoietic homeostasis through a negative feedback pathway in conditions of stress or agingHematopoietic stem cell responsiveness to exogenous signals is limited by caspase-3.Gene disruption of Spred-2 causes dwarfism.The Sprouty-related protein, Spred-1, localizes in a lipid raft/caveola and inhibits ERK activation in collaboration with caveolin-1.Endothelial progenitor cells and a stromal cell-derived factor-1α analogue synergistically improve survival in sepsis.Identification of SPRED2 (sprouty-related protein with EVH1 domain 2) as a negative regulator of the hypothalamic-pituitary-adrenal axis.Single nucleotide polymorphisms and haplotypes associated with feed efficiency in beef cattle.Spreds are essential for embryonic lymphangiogenesis by regulating vascular endothelial growth factor receptor 3 signaling.SPRED1 Interferes with K-ras but Not H-ras Membrane Anchorage and Signaling.Nonerythropoietic Erythropoietin-Derived Peptide Suppresses Adipogenesis, Inflammation, Obesity and Insulin Resistance.TGF-beta modulates the functionality of tumor-infiltrating CD8+ T cells through effects on TCR signaling and Spred1 expressionModeling cognitive dysfunction in neurofibromatosis-1Tumor suppressor Spred2 interaction with LC3 promotes autophagosome maturation and induces autophagy-dependent cell death.Diversity of polyproline recognition by EVH1 domains.Identification and functional analyses of 11,769 full-length human cDNAs focused on alternative splicing.Review and update of SPRED1 mutations causing Legius syndrome.Nonredundant functions for Ras GTPase-activating proteins in tissue homeostasis.NMR resonance assignments of the EVH1 domain of neurofibromin's recruitment factor Spred1.The many ways tissue phagocytes respond to dying cells.DYRK3 dual-specificity kinase attenuates erythropoiesis during anemiaA shared molecular mechanism underlies the human rasopathies Legius syndrome and Neurofibromatosis-1.Peptide array-based screening reveals a large number of proteins interacting with the ankyrin-repeat domain of the zDHHC17 S-acyltransferase.SPRED1, a RAS MAPK pathway inhibitor that causes Legius syndrome, is a tumour suppressor downregulated in paediatric acute myeloblastic leukaemia.SPREDs (Sprouty related proteins with EVH1 domain) promote self-renewal and inhibit mesodermal differentiation in murine embryonic stem cells.miR126 positively regulates mast cell proliferation and cytokine production through suppressing Spred1.
P2860
Q24324825-F610587D-D157-4077-BB0D-04BCC8BB0DA6Q24569770-37A0BD13-D8BD-42C0-B110-4A3576123B6CQ24656932-5845EB94-C456-49D4-87C6-91682C00222CQ30447724-D6E657C0-E609-4F3C-B7A4-077FBD94EADFQ30558805-F42B7859-78B9-499E-B82D-F1EF34B655E0Q33343173-8A144AF4-54FB-4859-9C04-8FB238F48E36Q33573588-B64538B7-DCE3-4878-BD69-496ED861C3D5Q34197553-7349C404-EC9A-4971-B1D1-3D998E210E19Q34346864-E20E9C4C-4C32-4F8F-AB5E-1E5264083A48Q34425218-12A14E31-D16E-4E13-BC6C-3799CC0A2FAEQ34444708-C72ED2C2-9595-43B0-A9C8-AFCC348DE7EFQ34480188-8D4D5F01-E3C9-4E17-9E1C-780B3FCB6B77Q34685293-6E738580-FAB1-4E67-A2FA-1BD08E3D5B4FQ34997619-1C07E235-1F29-481F-AA86-6B72E96EA481Q35857107-9317E5BC-608A-4826-921B-3343D86152CEQ36098356-144B79DD-6E1F-44A4-87C3-0FD70D8CB50EQ36150300-C6282F3D-9480-4E00-B131-F368EF6FE100Q36402151-3E967AA9-962D-4F5A-916C-D8EA4AFA99A0Q36756183-7E81DBA2-1903-4759-AC73-655A03B7E1C1Q37295451-F7C291C7-EFBE-4BE0-98A8-B65C56D6E496Q37410050-C87E488D-24C2-4A68-8E3C-D1755966D0E5Q37429412-FF234906-11DF-418D-838E-14ECB5EBCB31Q38023296-39E393F6-D8C0-4BB4-9544-5B0572115359Q38084894-1E7010C7-1381-493F-A658-687BE9700BDBQ38612981-87F167F9-8D4F-46C8-AF89-CF44ACEB3874Q39277496-52543EC8-BDB1-4A1E-9B04-2805D41DC974Q39929463-206A8077-8B99-4A4C-BACB-8987A60A73BCQ41877584-071A37E0-FE80-4482-8FEA-48488D18A432Q42636157-FDFCFB2D-D7C8-48D4-8032-EA630F80B24BQ48332997-48E56059-8C97-4663-B700-5BA9223C468EQ50600489-465BE021-67D3-422E-8E63-9C531CD00CE0Q54582374-214E50EA-2FD3-4494-A498-057132B66DB7
P2860
Spred-1 negatively regulates interleukin-3-mediated ERK/mitogen-activated protein (MAP) kinase activation in hematopoietic cells.
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Spred-1 negatively regulates i ...... vation in hematopoietic cells.
@ast
Spred-1 negatively regulates i ...... vation in hematopoietic cells.
@en
Spred-1 negatively regulates interleukin-3-mediated ERK/mitogen-activated protein
@nl
type
label
Spred-1 negatively regulates i ...... vation in hematopoietic cells.
@ast
Spred-1 negatively regulates i ...... vation in hematopoietic cells.
@en
Spred-1 negatively regulates interleukin-3-mediated ERK/mitogen-activated protein
@nl
prefLabel
Spred-1 negatively regulates i ...... vation in hematopoietic cells.
@ast
Spred-1 negatively regulates i ...... vation in hematopoietic cells.
@en
Spred-1 negatively regulates interleukin-3-mediated ERK/mitogen-activated protein
@nl
P2093
P2860
P356
P1476
Spred-1 negatively regulates i ...... vation in hematopoietic cells.
@en
P2093
Akihiko Yoshimura
Atsuo Sasaki
Atsushi Nonami
Daigo Yoshiga
Koji Taniguchi
Mine Harada
Reiko Kato
Satoru Fukuyama
Takaharu Taketomi
P2860
P304
52543-52551
P356
10.1074/JBC.M405189200
P407
P577
2004-09-30T00:00:00Z